4ITE | Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Kakuda, S., Takimoto-Kamimura, M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.49 | ||||||||||||
ligand | TEY | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Synthesis of 2alpha-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo., Matsuo M, Hasegawa A, Takano M, Saito H, Kakuda S, Chida T, Takagi K, Ochiai E, Horie K, Harada Y, Takimoto-Kamimura M, Takenouchi K, Sawada D, Kittaka A, ACS Med Chem Lett. 2013 May 28;4(7):671-4. doi: 10.1021/ml400098w. eCollection, 2013 Jul 11. PMID:24900728 |
Data retrieval |
View 4ITE in 3D |
Visual 3D analysis of 4ITE |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4ITE |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |